Suppression of CDCA3 inhibits prostate cancer progression via NFkappaB/cyclin D1 signaling inactivation and p21 accumulation. Gu P, Zhang M, Zhu J, He X, et al. Oncol Rep 2022;47.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gu P, Zhang M, Zhu J, He X, et al. Suppression of CDCA3 inhibits prostate cancer progression via NFkappaB/cyclin D1 signaling inactivation and p21 accumulation. Oncol Rep 2022;47.
PMID: 34970697